TFC-003

DRUG2 trials

Sponsors

Kukje Pharma

Conditions

Glaucoma Open-Angle PrimaryOcular HypertensionPrimary Open Angle Glaucoma

Phase 2

A Randomized, Open-label, Active-controlled, Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of TFC-003 in Patients With Primary Open-angle Glaucoma or Ocular Hypertension

Kukje PharmaOcular Hypertension, Primary Open Angle Glaucoma

Start: 2024-02-29End: 2024-09-30Target: 60Updated: 2023-12-20

Phase 3

[KJ-TFC-005] Phase 3 Study, Evaluate the Efficacy and Safety of TFC-003 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension

RecruitingNCT07662759

Kukje PharmaGlaucoma Open-Angle Primary, Ocular Hypertension

Start: 2025-12-09End: 2027-06-01Target: 188Updated: 2026-06-23